text-only page produced automatically by LIFT Text Transcoder Skip all navigation and go to page contentSkip top navigation and go to directorate navigationSkip top navigation and go to page navigation
National Science Foundation
News
design element
News
News From the Field
For the News Media
Special Reports
Research Overviews
NSF-Wide Investments
Speeches & Lectures
NSF Current Newsletter
Multimedia Gallery
News Archive
News by Research Area
Arctic & Antarctic
Astronomy & Space
Biology
Chemistry & Materials
Computing
Earth & Environment
Education
Engineering
Mathematics
Nanoscience
People & Society
Physics
 

Email this pagePrint this page
All Images


Press Release 05-011
Nanoscale Diagnostic Sets Sights on Alzheimer's

Experimental procedure detects possible traces of disease in cerebrospinal fluid

Back to article | Note about images

graph comparing diagnostic tools according to sensitivity and applicability to various bodily fluids

The bio-bar-code amplification technology, which is a million times more sensitive than enzyme-linked immunoassay (ELISA) tests, can detect ADDLs in cerebrospinal fluid where the biomarker is present in very low concentrations. The goal is to ultimately detect and validate the marker in blood.

Credit: Northwestern University


Download the high-resolution TIF version of the image. (113 KB)

Use your mouse to right-click (Mac users may need to Ctrl-click) the link above and choose the option that will save the file or target to your computer.



Email this pagePrint this page
Back to Top of page